Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,073 | -8,268 | -39,493 | -31,593 | -20,956 |
| Depreciation Amortization | 155 | 94 | 293 | 283 | 169 |
| Accounts receivable | -23 | -7 | -12 | -22 | -12 |
| Accounts payable and accrued liabilities | 602 | -366 | 309 | 322 | 508 |
| Other Working Capital | 740 | -1,240 | 571 | 190 | -1,221 |
| Other Operating Activity | 1,683 | 1,562 | 6,279 | 5,067 | 3,010 |
| Operating Cash Flow | $-13,916 | $-8,226 | $-32,052 | $-25,753 | $-18,501 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 30,675 | 6,903 | -11,687 | -12,617 | -8,962 |
| PPE Investments | -50 | -21 | -554 | -509 | -290 |
| Investing Cash Flow | $30,624 | $6,881 | $-12,241 | $-13,126 | $-9,252 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2 | N/A | 22 | 22 | 8 |
| Financing Cash Flow | $2 | $N/A | $22 | $22 | $8 |
| Beginning Cash Position | 22,543 | 22,543 | 66,814 | 66,687 | 66,687 |
| End Cash Position | 39,253 | 21,198 | 22,543 | 27,830 | 38,941 |
| Net Cash Flow | $16,711 | $-1,344 | $-44,271 | $-38,857 | $-27,746 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,916 | -8,226 | -32,052 | -25,753 | -18,501 |
| Capital Expenditure | -54 | -22 | -559 | -509 | -290 |
| Free Cash Flow | -13,969 | -8,248 | -32,612 | -26,262 | -18,791 |